Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aastrom Biosciences Inc Names Dominick C. Colangelo President And CEO

Wednesday, 6 Mar 2013 04:15pm EST 

Aastrom Biosciences Inc announced that the company's board of directors has named Dominick C. Colangelo, Esq., as President and Chief Executive Officer (CEO) of Aastrom. Mr. Colangelo will also serve as a member of the Aastrom board of directors. 

Company Quote

-0.02 -0.55%
11 Jul 2014